Herpes Zoster Market Overview
The herpes zoster market is expected to witness tremendous growth owing to rising incidence of herpes zoster coupled with rising geriatric population are factors contributing towards the growth of the market. Moreover, the risk of developing herpes zoster increases with age. However, challenges such as the limited number of pipeline agents for the treatment of herpes zoster despite the growing incidence of the infection worldwide is likely to curb the market growth during the forecast period.
The Herpes Zoster Market Trends is expected to get led by the US as the country has several patients who are suffering from the disease. It is projected to grow at a CAGR of 12.7% over the estimated period. In geriatric population, the chance of contracting disease is quite high and the mortality rate in the region is growing with the introduction of advanced medicines. This can be taken as an important thrust-provider. Advanced medicines are also going to have substantial impact on the global herpes zoster market.
Herpes zoster, also known as shingles, is a viral disease that is caused by the reactivation of varicella-zoster virus. The disease can be triggered by chicken pox. The global herpes zoster market is eyeing for an impressive rise during the forecast period. Market Research Future (MRFR), in their recently published article, revealed that one of the major factors to trigger the growth of this market is the impressive influence of government initiatives and expenditures in the research and development sector.
Herpes Zoster Market Segmentation
- The global herpes zoster market, as per the MRFR study, is segmented into diagnosis, treatment prevention, route of administration, and end-users.
- Based on the diagnosis, the herpes zoster market can be segmented into laboratory testing and others. The laboratory testing segment includes real-time Polymerase Chain Reaction (PCR), immunofluorescent microscopy, and serological testing.
- Based on the treatment and prevention segment, the herpes zoster market can be segmented into narcotic medications, antiviral medications, antihistamines, anti-inflammatory medications, capsaicin, anticonvulsants, gels, numbing creams, or patches, vaccines, and others.
- Based on the route of administration segment, the herpes zoster market comprises oral, topical, and others.
- Based on the end-user segment, the herpes zoster market consists hospitals clinics, diagnostic centers, home care settings, research academic institutes, and others. The hospitals clinics segment is gaining substantial head-start as they are the primary caregiver.
Herpes Zoster Market Regional Analysis:
The Americas, Europe, Asia Pacific (APAC), and the Middle East Africa (MEA) are four regions that have been included by MRFR in the study of global herpes zoster market.
The market in the Americas is quite big and it is growing with the support from governments of this region. The region also provides highly advanced healthcare facilities and spreads awareness regarding the infection.
The European region ranks second in terms of valuation. Emerging innovative vaccines for disease herpes zoster are expected to boost the regional market. The APAC and the MEA regions are expected to show substantial growth as effects of the disease is rising. The APAC market is going to benefit from the evolving healthcare infrastructures in emerging economies. In the coming years, the MEA market has the potential to emerge as the fastest growing region. However, the African region may hold back the growth as poor countries from the region are lacking proper healthcare infrastructure and expertise.
Herpes Zoster Market Players
- Astellas Pharma Inc.
- Foamix Pharmaceuticals
- GeneOne Life Science
- GlaxoSmithKline plc
- Merck Co.
- NAL Pharma
- Novartis AG
- Hoffmann-La Roche Ltd
- TSRL Inc.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/herpes-zoster-market-7137
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
